Island Pharmaceuticals Ltd (ILA) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Island Pharmaceuticals Ltd (ASX:ILA), currently being evaluated. In 2024, Island Pharmaceuticals Ltd generated $118,910 in revenue and -$2.77 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Island Pharmaceuticals Ltd is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: N/A
- Recent Revenue (2024): $118,910
- Free Cash Flow (2024): -$2.77 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.